The company expired its plan on November 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.15 CNY | -1.25% | -5.12% | -6.97% |
04-29 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.97% | 4.17B | |
+17.33% | 29.26B | |
+14.70% | 1.83B | |
-11.98% | 626M | |
-11.83% | 454M | |
-81.65% | 216M | |
-12.48% | 112M | |
-12.32% | 53.63M |
- Stock Market
- Equities
- 688065 Stock
- News Cathay Biotech Inc.
- Cathay Biotech Inc.'s Equity Buyback announced on March 30, 2022, has expired with 1,133,035 shares, representing 0.19% for CNY 94.57 million.